Merck reported EUR9.2B in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Adidas ADS:GR EUR 5.29B 990M
Adyen ADYEN:NA EUR 169.87M 21.09M
Akzo Nobel AKZA:NA EUR 3.33B 30M
Alcon AG ALC:SW USD 4.9B 710M
Amadeus IT AMS:SM EUR 3.09B 751.8M
AstraZeneca AZN:LN USD 23.69B 9M
Bayer BAYN:GR EUR 33.79B 5.67B
Covestro 1COV:GR EUR 3.37B 1.03B
Galapagos GLPG:NA EUR 14.69M 1.07M
Genmab GEN:DC DKK 523M 27M
Givaudan GIVN:VX CHF 4.65B 350M
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Hikma Pharmaceutical HIK:LN USD 1.14B 279M
Infineon Technologie IFX:GR EUR 5B 217M
Linde LIN:GR USD 12.2B 1.59B
Lonza Group LONN:SW CHF 1.55B 393M
Merck MRK:GR EUR 9.2B 66M
Novartis NOVN:VX USD 21.78B 547M
Roche Holding ROG:VX 21.39B 978M